New technologies and strong academic-industry partnerships have the potential to change the face of therapeutic medicine.

Graphical representation of COVID-19 and network analysis

Scientists identify 160 new drugs that could be repurposed against COVID-19

30 Jun 2021

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19...

Read more

Heal thyself: looking for new ways to treat neurodegeneration

24 May 2021

Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore...

Read more
Human cells with acute myelocytic leukemia, shown with an esterase stain at 400x

Scientists develop new class of cancer drug with potential to treat leukaemia

26 Apr 2021

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published...

Read more

Screening for glaucoma

Gene therapy technique shows potential for repairing damage caused by glaucoma and dementia

31 Mar 2021

Scientists at the University of Cambridge have shown in animal studies that gene therapy may help repair some of the damage caused in chronic...

Read more

Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable

22 Mar 2021

UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection...

Read more
Creative rendition of SARS-COV-2 virus particles

Remdesivir likely to be highly effective antiviral against SARS-CoV-2 for some patients

14 Dec 2020

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in...

Read more


Recruitment underway as Cambridgeshire NHS trusts join COVID-19 vaccine trial

11 Jun 2020

Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.

Read more

Repurposing existing drugs for COVID-19 a more rapid alternative to a vaccine, say researchers

07 May 2020

Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and...

Read more

Cambridge research team working towards vaccine against COVID-19

17 Mar 2020

The race is on to find a vaccine against the new COVID-19 coronavirus. Professor Jonathan Heeney explains why a cautious approach is needed and how...

Read more

World’s first artificial pancreas app licensed for people with type 1 diabetes in UK

16 Mar 2020

The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes launches today, based on over a decade of research...

Read more

Study highlights potential for ‘liquid health check’ to predict disease risk

02 Dec 2019

Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we...

Read more

Strategic partner: AstraZeneca

11 Nov 2019

Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge University for more than two decades. What are the...

Read more